Admission to Trading

Summary by AI BETAClose X

IMI PLC announced the admission of 873 further ordinary shares of 28 4/7 pence each to trading on the London Stock Exchange's Main Market on September 8, 2026, pursuant to its US Stock Purchase Plan. These newly admitted shares are fully fungible with the company's existing ordinary shares, bringing the total number of securities admitted to trading to 249,715,307. This admission is a routine event related to employee share plans and is not expected to have a material impact on the company's overall share structure or valuation.

Disclaimer*

IMI PLC
08 September 2026
 

IMI PLC

8 September 2026

NOTIFICATION OF ADMISSION OF FURTHER SECURITIES TO TRADING

IMI plc ("IMI" or the "Company") announces, in accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, that the following shares have been admitted to trading on the Main Market of the London Stock Exchange pursuant to their allotment under the Company's US Stock Purchase Plan.

1

Details of the issuer

a)

Name

IMI PLC

b)

LEI

2138002W9Q21PF751R30

2

Details of the transferable securities admitted to trading

a)

Name, type and identification code

Ordinary Shares of 28 4/7 pence each

 

ISIN: GB00BGLP8L22

b)

Regulated market

London Stock Exchange - Main Market

c)

Number of further securities admitted to trading covered by this notification

873

d)

Total number of securities admitted to trading following admission

249,715,307

e)

Fungibility

Fully fungible with existing Ordinary Shares

3

Admission details

a)

Date of admission

8 September 2026

b)

Prospectus information

N/A

 

For further information, please contact:

Louise Waldek

Company Secretary

0121 717 3700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

IMI (IMI)
UK 100

Latest directors dealings